Benjamin Singer represents multinational corporations and their boards and executives in high-stakes criminal and civil investigations by the U.S. Department of Justice, Securities and Exchange Commission, and other federal and state agencies. Ben joined O’Melveny after a decade at DOJ, where he most recently served as Chief of the Department of Justice’s Securities & Financial Fraud Unit. In this role, Ben was the lead prosecutor on several of the largest cross-border cases in DOJ history, including Volkswagen’s alleged evasion of U.S. emissions standards, the foreign exchange manipulation cases, and cases alleging LIBOR manipulation. Prior to that, Ben was the Chief of the DOJ’s Health Care Fraud Unit, where he supervised corporate health care prosecutions involving major health care providers, pharmaceutical manufacturers, and medical device manufacturers.
As Chief of the DOJ’s Securities & Financial Fraud Unit, Ben oversaw approximately 50 federal prosecutors investigating complex securities, commodities, and other corporate fraud and corruption offenses, including market manipulation, spoofing, insider trading, accounting fraud, procurement fraud, money laundering, environmental crimes, antitrust offenses, and bribery.
As Chief of the DOJ’s Health Care Fraud Unit, Ben supervised a team of over thirty prosecutors that prosecuted offenses in the health care industry, including fraud, kickbacks, money-laundering, and FCPA-related offenses.
Ben is a formidable trial lawyer, having served as first-chair trial counsel in eight felony white-collar jury trials during his time at the DOJ. His work twice earned him the DOJ’s highest honor: the Attorney General’s Award.
Prior to his government service, Ben worked in the New York office of two international law firms.
- Chief, Securities & Financial Fraud Unit, Fraud Section, Criminal Division, U.S. Department of Justice (2014–2018)
- Chief, Health Care Fraud Unit, Fraud Section, Criminal Division, U.S. Department of Justice (2013–2014)
- Assistant Chief, Fraud Section, Criminal Division, U.S. Department of Justice (2011–2014)
- Trial Attorney, Fraud Section, Criminal Division, U.S. Department of Justice (2009–2011)
Honors & Awards
- Attorney General’s Award for Distinguished Service (2016)
- Attorney General’s Award for Fraud Prevention (2012)
- Department of Justice Director’s Award (2018)
- Assistant Attorney General’s Award for Exceptional Service (2011, 2015)
- Assistant Attorney General’s Award for Distinguished Service (2010, 2014)
- Inspector General of the Department of Health and Human Services’ Integrity Award (2011)
- US District Court, Southern District of New York
- US District Court, Eastern District of New York
*Admitted only in New York; supervised by principals of the firm.
- Cornell Law School, J.D., 2002
- The College of William & Mary, B.A., 1999: with honors
- “Second Circuit Decision Limits FCPA Jurisdiction as to Foreign Nationals Outside the United States,” O’Melveny & Myers LLP Client Alert (Aug. 28, 2018)
- “Federal Appeals Court Refuses to Void Criminal Service of Process on Counsel for Foreign Corporation Making Limited Appearance,” O’Melveny & Myers LLP Client Alert (Aug. 23, 2018)
- “California Decision Distorts Bank Liability Under FIRREA,” Law360 (July 17, 2018)
- UT Law 5th Annual Government Enforcement Institute, “Financial Fraud Enforcement Trends: A Conversation with the SEC and DOJ” (September 20-21, 2018)
- Practicing Law Institute, Swaps and Derivatives and Market Enforcement, Panelist, “Perspectives from Government Agencies” (2016, 2017)
- SEC & DOJ Hot Topics, Panelist, “Current Developments Materially Affecting Corporations, Financial Institutions, Individuals” (2016, 2017)
- University of Texas School of Law, Annual Government Enforcement Institute, Keynote Speaker (2017); Panelist, “Current Trends in Criminal and Civil Investigations” (2015)
- SIFMA, Compliance & Legal Annual Seminar, Panelist, “US and Global Market Abuses: Price Manipulation and Other Issues” (2016)
- FDIC/DOJ Financial Crimes Conference, Keynote Speaker (2016) (included approximately 500 government-only participants)
- Securities Litigation and Regulatory Practice Seminar, Panelist, “Enforcement Developments” (2016)
- ABA Business Law Section, Derivatives & Futures Law Committee Winter Meeting, Panelist, “Enforcement/Litigation Developments” (2015)
- American Bar Association, National Institute on Securities Fraud, Panelist, “Wall Street to the Hill: The Continuing Evolution of Insider Trading Investigations” (2014); Panelist, “Enforcement Priorities” (2015)
- National Health Care Anti-Fraud Association, Annual Training Conference, Speaker “Medicare Fraud Strike Force and Beyond” (2011, 2012); Speaker, “Summary Evidence in Health Care Prosecutions” (2012)